Back

Nuclear scintigraphy: the key to non-invasive diagnosis of ATTR-CM.

10 May 2021 (16:30 - 16:40)
Organised by:
Congress Presentation Part of: Using nuclear scintigraphy to accelerate the diagnosis of ATTR-CM Inflammation, Infection, and Infiltrative Cardiovascular Disorders Open Access ICNC-CT 2021

About the speaker

Photo
Doctor Sharmila Dorbala

Brigham and Women's Hospital, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Doctor S. Dorbala (Boston, US)
Video
Presentation thumbnail
ATTR-CM: Raising suspicion of a complex disease.
Doctor S. Stampfli (Lucerne, CH)
Video
Presentation thumbnail
Sharing experiences of a collaborative approach to diagnosing ATTR-CM.
Doctor R. Bonfiglioli (Bologna, IT)
Video
Presentation thumbnail
Q&A / discussion.
Video

Access the full session

Session thumbnail
Using nuclear scintigraphy to accelerate the diagnosis of ATTR-CM
Video

The Event

Event poster

ICNC-CT 2021

10 May 2021 16:30 CET
You may be interested in
thumbnail
Congress Presentation
Beyond standard imaging in hereditary transthyretin amyloidosis: a diagnostic challenge
30 August 2026
thumbnail
Congress Presentation
Regional cardiac uptake of 99-Tc-DPD is a novel powerful and independent prognostic marker in cardiac ATTR wild type amyloidosis.
31 August 2020
thumbnail
Congress Session
ATTRibutes of change: advances in treating and monitoring ATTR-CM
17 May 2025
thumbnail
Congress Presentation
Current practices and access to cardiac bone scans for the detection of transthyretin cardiac amyloidosis based on the results of a large national electronic survey
20 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources